Sei Investments CO Sage Therapeutics, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $172,599 - $252,806	-4,246 Reduced 46.65%	4,855 $228,000
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $339,194 - $423,833	9,101 New	9,101 $381,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $33,409 - $44,784	1,035 Added 14.43%	8,207 $321,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $197,373 - $272,464	7,172 New	7,172 $231,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $2.21 Million - $3.15 Million	-54,860 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$54.88 - $79.29 $165,353 - $238,900	3,013 Added 5.81%	54,860 $3.13 Million
Q1 2021 May 12, 2021	BUY	$70.65 - $96.76 $114,664 - $157,041	1,623 Added 3.23%	51,847 $3.94 Million
Q4 2020 Feb 08, 2021	BUY	$58.41 - $89.06 $793,499 - $1.21 Million	13,585 Added 37.08%	50,224 $4.33 Million
Q3 2020 Dec 04, 2020	SELL	$41.13 - $62.45 $987 - $1,498	-24 Reduced 0.07%	36,639 $2.24 Million
Q3 2020 Nov 06, 2020	BUY	$41.13 - $62.45 $336,484 - $510,903	8,181 Added 28.72%	36,663 $2.24 Million
Q2 2020 Aug 17, 2020	SELL	$25.95 - $43.15 $85,193 - $141,661	-3,283 Reduced 10.34%	28,482 $1.18 Million
Q2 2020 Aug 11, 2020	BUY	$25.95 - $43.15 $253,401 - $421,359	9,765 Added 44.39%	31,765 $2.29 Million
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $280,824 - $829,480	-10,739 Reduced 32.8%	22,000 $606,000
Q4 2019 Feb 06, 2020	SELL	$60.18 - $154.77 $1.92 Million - $4.95 Million	-31,969 Reduced 49.41%	32,739 $2.35 Million
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $284,648 - $385,428	2,029 Added 3.24%	64,708 $9.07 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $1.05 Million - $1.22 Million	6,640 Added 11.85%	62,679 $11.5 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $4.58 Million - $8.38 Million	51,237 Added 1066.99%	56,039 $8.9 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $29,908 - $50,994	365 Added 8.23%	4,802 $641,000
Q3 2018 Nov 08, 2018	SELL	$138.11 - $169.04 $944,258 - $1.16 Million	-6,837 Reduced 60.64%	4,437 $622,000
Q2 2018 Aug 03, 2018	BUY	$140.36 - $175.76 $1.58 Million - $1.98 Million	11,269 Added 225380.0%	11,274 $1.76 Million
Q1 2018 May 11, 2018	BUY	$152.15 - $192.33 $760 - $961	5 New	5 $1,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account